Barentz, a distributor of life science ingredients, opened a new pharmaceutical development center in Mexico City. According to the company, the state-of-the-art facility represents a significant milestone in its commitment to innovation and will serve as a collaboration hub for pharmaceutical and nutraceutical manufacturers in North America.

The new center is designed to foster collaboration and drive formulation excellence to produce the most effective treatments. The facility is fully equipped to offer technical support and training to customers and suppliers.

The new facility will focus on a range of key formulation areas, including formulation development & analytical characterization for both oral solids and liquid dosage forms. This includes suggesting suitable ingredients and assisting in the formulation and refinement of pharmaceutical products.

“With the opening of this facility, Barentz is showing its commitment to the pharmaceutical and nutritional markets in not only Mexico but the broader N. American region,” said Julio Rendon, Mexico managing director. “This will help reduce the time it takes for customers to develop and launch new products. Barentz’ investment demonstrates our dedication to providing top-notch products and services.”

“The inauguration of this site is a testament to Barentz’ commitment to become a global market leader in the pharmaceutical segment,” said Mike McKenna, CEO, Barentz North America. “We are incredibly excited to invest in our commercial and technical teams who collaborate with our Principal partners to deliver value for the benefit of our customers every day.